ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Long Circulating Cancer Cell-Targeted Bionic Nanocarriers Enable Synergistic Combinatorial Therapy in Colon Cancer

Zheng, Yunsheng; Guo, Wenfeng; Hu, Lingwei; Xiao, Zekai; Yang, Xianzhu*; Cao, Ziyang*; Cao, Jie*2
ACS applied materials & interfaces2023-5-3DOI: 10.1021/acsami.3c00469
2被引9阅读
引用收藏
分享

摘要

Cancer nanomedicine treatment aims to achieve highly specific targeting and localization to cancer cells. Coating of nano-particles with cell membranes endows them with homologous cellular mimicry, enabling nanoparticles to acquire new functions and properties, including homologous targeting and long circulation in vivo, and can enhance internalization by homologous cancer cells. Herein, we fused a human-derived HCT116 colon cancer cell membrane (cM) with a red blood cell membrane (rM) to fabricate an erythrocyte-cancer cell hybrid membrane (hM). Oxaliplatin and chlorin e6 (Ce6) co-encapsulated reactive oxygen species-responsive nanoparticles (NPOC) were camou-flaged by hM and obtained a hybrid biomimetic nanomedicine (denoted as hNPOC) for colon cancer therapy. hNPOC exhibited prolonged circulation time and recognized homologous targeting ability in vivo since both rM and HCT116 cM proteins were maintained on the hNPOC surface. hNPOC showed enhanced homologous cell uptake in vitro and considerable homologous self-localization in vivo, producing effective synergistic chemophotodynamic therapy efficacy under irradiation with a homologous HCT116 tumor compared to that with a heterologous tumor. Together, the biomimetic hNPOC nanoparticles showed prolonged blood circulation and preferential cancer cell-targeted function in vivo to provide a bioinspired strategy for chemophotodynamic synergistic therapy of colon cancer.

学科与关键词

关键词
biomimetic nanoparticleshybrid membrane coatingprolonged circulationhomologous targetingcolon cancerchemophotodynamic synergistic therapy
相关
加载中…
  • Construction of Biomimetic-Responsive Nanocarriers and their Applications in Tumor Targeting
    Tian, Xuexia; Shi, Anhua*; Wu, Junzi*Anti-Cancer Agents in Medicinal Chemistry, 2022, 22(12): 2255-2273.被引 4
  • Biomimetic erythrocytes engineered drug delivery for cancer therapy
    Zhang, Wenyuan; Zhao, Man; Gao, Yali; Cheng, Xu; Liu, Xiaoying; Tang, Shukun; Peng, Yanbo; Wang, Na; Hu, Dandan; Peng, Haisheng*; Zhang, Jinqiu*; Wang, Qun*Chemical Engineering Journal, 2022, 433: 133498.被引 18
  • Study on biomimetic nano tumor targeted delivery system for chemotherapy-laser immunotherapy
    Liu, Yang*; Wang, Tong; Ren, Yachao; Li, Shuli; Fu, Jijun*; Shi, Jun*European Journal of Pharmaceutics and Biopharmaceutics, 2022, 176: 133-152.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
ACS applied materials & interfaces
发表日期
2023-05-03
卷期
第 15 卷, 第 19 期
页码
22843-22853
DOI
10.1021/acsami.3c00469
语言
ENGLISH
成果收录
SCIE
资助标注
National Key R&D Program of China [2022YFD2401900]; National Natural Science Foundation of China [81871943,82173236, 52203163]; program of Guangdong Provincial Clinical Research Center for Digestive Diseases [2020B1111170004]; Science and Technology Planning Project of Guangdong Province [202206080008]

作者

  • Z

    Zheng, Yunsheng (第一作者)

    2

  • G

    Guo, Wenfeng

    2

查看全部 7 位作者收起作者
  • H

    Hu, Lingwei

  • X

    Xiao, Zekai

  • Y

    Yang, Xianzhu (通讯)

  • C

    Cao, Ziyang (通讯)

    2

  • C

    Cao, Jie (通讯)

    2

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417